CPRX Catalyst Pharmaceuticals Earnings and EPS analysis

EPS in 2026 (TTM): $1.81

Last Report Period Date: Mar 31, 2026

Based on the company's latest reports for March 2026, the EPS for the trailing twelve months is $1.81. Catalyst Pharmaceuticals's earnings per share in 2025 amounted to $1.75, marking an increase from $1.38 in 2024. During the quarterly period ending on Mar 31, 2026, CPRX's earnings per share stood at $0.52.

Catalyst Pharmaceuticals had an yealy EPS of $1.75, indicating an increase of 26.8% from $1.38 recorded in 2024. The quarterly per-share earnings for the period ending Mar 31, 2026, was $0.52, indicating a 10.6% increase compared to the same quarter last year. CPRX's 12-month EPS is $1.81 as of March 2026. Catalyst Pharmaceuticals's annual EPS in 2024 was $1.38, a 106% rise year-over-year.

Catalyst Pharmaceuticals has registered a growth in earnings per share of 10.6% over the past 12 months (YoY, quarterly). Examining a broader timeline, the company recorded an average EPS annual growth rate of 29.8% per year for the last 3 years. Catalyst Pharmaceuticals had an average annual EPS growth of 19.4% during the last five years.